This journal only 2015, Number 1-4 Rev Mex Cir Endoscop 2015; 16 (1-4) Mid-term diabetes remission after bariatric surgery among Mexicans: a comparison between laparoscopic gastric bypass and sleeve gastrectomy Zerrweck-López C, Pereyra-Talamantes A, Maydón-González HG, Fernández-Silva I, Campos-Pérez F, Guilbert-Vertiz L Full text How to cite this article Language: Spanish References: 33 Page: 13-18 PDF size: 222.37 Kb. Key words: Type 2 diabetes mellitus, obesity, bariatric surgery, laparoscopic gastric bypass, sleeve gastrectomy, hispanic population, Mexicans. ABSTRACT Background: Type 2 diabetes mellitus is one of the most common comorbidities associated with obesity, causing the greatest burden in low- and middle-income countries. Ethnicity plays a role, where latin population has higher risk for diabetes onset. Diabetes remission following bariatric surgery has been observed, but few studies are available in Mexicans. The primary objective was to analyze diabetes remission and compare between procedures; weight loss was also analyzed. Material and methods: Retrospective study comparing 84 obese patients with diabetes, submitted to either laparoscopic gastric bypass (n = 62) or laparoscopic sleeve gastrectomy (n = 22) between 2009 to 2011 at a single institution. Results: Female sex comprised 72.6% of all cases. Both groups had comparable metabolic profiles at baseline. At 12 months both groups improved in fasting glucose plasma and Hb1Ac% without statistical differences and continued after 18 months. Overall remission was observed in 76.1% of patients; complete remission in 65.4% and partial remission in 10.7% without difference between procedures. Weight loss was greater for the gastric bypass group. Conclusions: Both bariatric procedures are effective methods for diabetes remission after one year among Mexicans. No differences were observed between procedures for complete and partial remission. Gastric bypass showed better weight loss. REFERENCES Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011; 378: 31-40. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. [consultado 16 de febrero del 2015]. Available in: http://www.cdc.gov/diabetes/statistics/prev/national/figbyhispanic.htm Barquera S, Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Rivera-Dommarco JA. Prevalencia de obesidad en adultos mexicanos, 2000-2012. Salud Pública Méx. 2013; 55: S151-S160. Sudan R, Winegar D, Thomas S, Morton J. Influence of ethnicity on the efficacy and utilization of bariatric surgery in the USA. J Gastrointest Surg. 2014; 18: 130-136. Pories WJ, Caro JF, Flickinger EG, Meelheim HD, Swanson MS. The control of diabetes mellitus (NIDDM) in the morbidly obese with the greenville gastric bypass. Ann Surg. 1987; 206: 316-323. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222: 339-350; discussion 350-2. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE et al How do we define cure of diabetes? Diabetes Care. 2009; 32: 2133-2135. Pournaras DJ, Aasheim ET, Sovik TT, Andrews R, Mahon D, Welbourn R et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012; 99: 100-103. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. BMJ. 2013; 347: f5934. Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery versus conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014; 24: 437-455. Heindorff H, Hougaard K, Larsen PN. Laparoscopic adjustable gastric band increases weight loss compared to dietary treatment: a randomized study. Obes Surg. 1997; 7: 300-301. Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract. 2013; 101: 50-56. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366: 1577-1585. Schauer PR, Kashyap SR, Wolski K, Brethauer S, Kirwan J, Pothier C et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012; 366: 1567-1576. Saydah S, Tao M, Imperatore G, Gregg E. GHb level and subsequent mortality among adults in the U.S. Diabetes Care. 2009; 32: 1440-1446. Robert M, Ferrand-Gaillard C, Disse E, Espalieu P, Simon C, Laville M et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg. 2013; 23: 770-775. Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013; 23: 1994-2003. Nosso G, Angrisani L, Saldalamacchia G, Cutolo P, Cotugno M, Lupoli R et al. Impact of sleeve gastrectomy on weight loss, glucose homeostasis, and comorbidities in severely obese type 2 diabetic subjects. J Obes. 2011; 2011: 340867. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011; 146: 143-148. Abbatini F, Capoccia D, Casella G, Soricelli E, Leonetti F, Basso N. Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy. Surg Obes Relat Dis. 2013; 9: 498-502. Vidal J, Ibarzabal A, Romero F, Delgado S, Momblán D, Flores L et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008; 18: 1077-1082. Residori L, Garcia-Lorda P, Flancbaum L, Pi-Sunyer FX, Laferrere B. Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race. Obes Surg. 2003; 13: 333-340. Bermudez OI, Tucker KL. Total and central obesity among elderly Hispanics and the association with Type 2 diabetes. Obes Res. 2001; 9: 443-451. Winkleby MA, Kraemer HC, Ahn DK, Varady AN. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA. 1998; 280: 356-362. Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006; 29: 1585-1590. Menke A, Rust KF, Savage PJ, Cowie CC. Hemoglobin A1c, fasting plasma glucose, and 2-hour plasma glucose distributions in U.S. population subgroups: NHANES 2005-2010. Ann Epidemiol. 2014; 24: 83-89. Coleman KJ, Huang YC, Koebnick C, Reynolds K, Xiang AH, Black MH et al. Metabolic syndrome is less likely to resolve in hispanics and non-Hispanic blacks after bariatric surgery. Ann Surg. 2014; 259: 279-285. Admiraal WM, Celik F, Gerdes VE, Dallal RM, Hoekstra JB, Holleman F. Ethnic differences in weight loss and diabetes remission after bariatric surgery: a meta-analysis. Diabetes Care. 2012; 35: 1951-1958. De la Cruz-Muñoz N, Messiah SE, Arheart KL, Lopez-Mitnik G, Lipshultz SE, Livingstone A. Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. J Am Coll Surg. 2011; 212: 505-511. Dixon JB, Dixon AF, O’Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med. 2003; 20:127-134. Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010; 20: 1245-1250. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013; 9: 379-384. O’Rourke RW, Andrus J, Diggs BS, Scholz M, McConnell DB, Deveney CW. Perioperative morbidity associated with bariatric surgery: an academic center experience. Arch Surg. 2006; 141: 262-268.